Back

Efficacy and safety of cangrelor on top of anticoagulation in patients with myocardial infarction related cardiogenic shock or cardiac arrest receiving va ecmo: preliminary data from a phase 2 trial

19 February 2026 (08:00 - 18:30)
Organised by: Logo
Congress Presentation Part of: Mechanical circulatory devices: cardiogenic shock & beyond Cardiogenic Shock EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

About the speaker

Photo
Doctor Pasquale Nardelli

IRCCS San Raffaele Scientific Institute, Milan (Italy)

5 More presentations in this session

Presentation thumbnail
Mechanical circulatory support with microaxial flow pump for high-risk PCI: a comparative analysis in left main disease
Doctor G. Botti (Milan, IT)
Abstract Slides
Presentation thumbnail
One-year outcomes of high-risk percutaneous coronary interventions with versus without mechanical circulatory support: propensity score-matched analysis.
Miss E. Blazejowska (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Use of pulmonary artery catheters during ImpellaTM-protected high risk percutaneous coronary intervention: a single centre experience
Doctor K. Wales (Sydney, AU)
Abstract Slides
Presentation thumbnail
Major bleeding complication in patients with CS on Impella and undergoing Impella assisted high risk percutaneous coronary intervention. Results of IMPELLA PL registry.
Doctor K. Pilawska (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Bleeding complication in prolonged transaxillary support with microaxial flow pump for acute myocardial infarction cardiogenic shock: insights from a referral center
Doctor P. Nardelli (Milan, IT)
Abstract Slides

Access the full session

Session thumbnail
Mechanical circulatory devices: cardiogenic shock & beyond

The Event

Event poster

EAPCI Summit 2026

19 February - 20 February 2026

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources